Secondary Neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Immunohistochemical expression was found for MMP-14 in all primary tumors as well as in all metastases and for MMP-2 expression in most of the samples.
|
30741846 |
2020 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
In ATAT for the group of patients with distant metastasis (M1) the superoxide generation rate, MMP-2, 9 activities are about 2 times higher (p < 0.05) than in the subgroup without distant metastases (M0).
|
31711773 |
2020 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
Furthermore, the down-regulation of matrix metalloprotein 2 (MMP2) and MMP9 also reduce the rate of tumor metastasis.
|
31136911 |
2019 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
Functional analyses revealed that PLOD3 interacts with STAT3, thereby expressing matrix metalloproteinases (MMP-2 and MMP-9) and with urokinase plasminogen activator (uPA) to enhance tumor metastasis.
|
30442941 |
2018 |
Secondary Neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In addition, scratch and invasion assay showed that HBC also dose-dependently suppressed migration and invasion capacities of highly metastatic HCC HepG2 cells through down-regulated the expression of tumor metastasis related proteins MMP-2 and MMP-9, significantly better than SAHA.
|
29428472 |
2018 |
Secondary Neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
These results suggested that exosomal lnc-MMP2-2 might regulate the migration and invasion of lung cancer cells into the vasculature by promoting MMP2 expression, suggesting this lncRNA as a novel therapeutic target and predictive marker of tumor metastasis in lung cancer.
|
30256540 |
2018 |
Secondary Neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Treatment with the KiSS1 peptide or with a synthesis peptide with longer half-life, the FTM080, significantly inhibited cell proliferation, migration and invasion of mesothelioma cell lines; the same treatment reduced the activity of MMP-2 and MMP-9 determining consequently a marked reduction in the invasiveness of primary tumors and metastases.
|
29721201 |
2018 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
Choroidal melanoma is the most common intraocular tumor in adults, and overexpression of matrix metalloproteinase-2 or matrix metalloproteinase-9 (MMP-2/MMP-9) is associated with angiogenesis and tumor metastasis of the choroidal malignant melanoma (CMM).
|
29260433 |
2018 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
The expression levels of the cell apoptosis and tumor metastasis associated proteins B‑cell lymphoma 2 (Bcl‑2), Bcl‑2‑associated X protein, E‑cadherin, Twist, matrix metalloproteinase (MMP)‑9 and MMP2 were measured via western blotting.
|
29845265 |
2018 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
Statistically significant differences in MMP-2 and TIMP-2 concentrations between patients with T1 and T2 tumour and patients with T3 and T4 tumour, as well as between the group without metastases (N0) and the group with metastases to lymph nodes were demonstrated.
|
29312740 |
2017 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis.
|
27987367 |
2017 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
In particular, HMGB1/RAGE is involved in tumor metastasis by inducing matrix metalloproteinase 2 (MMP2) and MMP9 expression.
|
28382092 |
2017 |
Secondary Neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Taken together, our results demonstrate that activation of ERβ in lung cancer cells promotes tumor metastasis through increasing expression of invasiveness-associated MMP-2.
|
28915603 |
2017 |
Secondary Neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tumor metastasis model in vivo showed much more metastatic nodules of lung in the Dicer knockdown group than the control group via increased MMP-2 expression.
|
27732931 |
2016 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
We found that loss of host MMP2 reduces the proliferation of experimental metastases in the lungs and identified fibroblasts in tumour-bearing lungs as the major source of MMP2.
|
25469981 |
2015 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
Bioinformatics analysis combined with tumor metastasis PCR array showed that matrix metalloproteinase 2 (MMP2) and PTEN could be important target genes of miR-29b.
|
26063204 |
2015 |
Secondary Neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The significant dose dependent down regulation of MMP-2 and MMP-9 in treated cells demonstrated that isolated saponins can decline tumor metastasis in vitro.
|
26107236 |
2015 |
Secondary Neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The inverse correlation of MMP-2 and miR-328 was also observed in tumor specimens, and MMP-2 expression was linked to tumor metastasis.
|
25605016 |
2015 |
Secondary Neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
This study aims to investigate the impacts of CO2 pneumoperitoneum on the growth of ovarian cancer in nude mice and the expression of tumor metastasis suppressor gene (NM23-H1) and matrix metalloproteinase -2 (MMP-2) in SKOV-3 ovarian cancer cell line cancer tissue.
|
25141992 |
2015 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
In addition, increasing numbers of reports provide evidence that MMPs, especially MMP2 and MMP9 are monitored by various signal transduction pathways targeting tumor metastasis.
|
26058729 |
2015 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
JWA, a multifunctional microtubule-binding protein, plays an important role in regulating tumor metastasis via inhibition of matrix metalloproteinase-2 (MMP-2).
|
24072772 |
2014 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
Matrix metalloproteinase 2 (MMP2) is a master regulator of tumor metastasis.
|
25251472 |
2014 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
Matrix metalloproteinase 2 (MMP-2) in metastatic cancer tissue, which is associated with a poor prognosis, is a potential target for tumor imaging in vivo.
|
25547485 |
2014 |
Secondary Neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tumor Metastasis PCR Array demonstrated that 24 h microcystin-LR treatment (25 nM) caused overexpression of eight genes involved in tumor metastasis, including MMP-2, MMP-9, and MMP-13.
|
22992115 |
2012 |
Secondary Neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
SCH66336 treatment also reduced the expression and activity of the urokinase-type plasminogen activator (uPA) and matrix metalloproteinase 2 (MMP-2), both important regulators of tumor metastasis.
|
22113431 |
2012 |